Market Research Logo

Hyaluronic Acid Products Market: Three Cycle Injection Products Segment to Remain Dominant Throughout the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Hyaluronic Acid Products Market: Three Cycle Injection Products Segment to Remain Dominant Throughout the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Cohesive report structure that flows in a logical format

Hyaluronic acid is a glycosaminoglycan widely distributed throughout neural, epithelial, and connective tissue. The report titled ‘Hyaluronic Acid Products Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027’ sheds light on the different factors poised to impact growth of the hyaluronic acid products market during the course of the forecast period. The report begins with a succinct yet comprehensive executive summary for a first-glance that encapsulates the market overview, analysis, and recommendations. An introduction to the global hyaluronic acid products market that consists of the definition and taxonomy follows. An in-depth assessment of the macroeconomic factors such as regulations, opportunity analysis, revenue growth, and the global value chain is par for the course. The historical analysis of the hyaluronic acid products market for the period 2012- 2026 is compared and contrasted with the decadal forecast to present a complete picture of the present and future prospects in the hyaluronic acid products market.

The successive chapters highlight the value forecast of the hyaluronic acid products market across the studied regions. The crucial market dynamics along with an impact analysis of the drivers and restraints that influence the hyaluronic acid products market are provided herein. A forecast of the hyaluronic acid products market for the various market segments and sub-segments for the regions is mentioned. The regional sections conclude with a market attractiveness index along with their relevance and impact on the overall hyaluronic acid products market.

A crucial chapter of the hyaluronic acid products market report focuses on the competitive landscape. The section touches on the market structure, competition intensity map on the basis of the taxonomy, and an exhaustive competition dashboard featuring prominent companies actively involved in the hyaluronic acid products market. The leading companies have been profiled with information on their product portfolio, business strategies, recent developments, and financials. Another section of the hyaluronic acid products market report delivers a revenue forecast for market segments within specific regions. The informative report ends with a brief dive into the research methodology adopted to arrive at accurate estimations of the hyaluronic acid products market with an index of assumptions and acronyms used throughout the report.

Flowchart of the research methodology

Future Market Insights has devised a robust research methodology that can be considered an industry benchmark. The research methodology is highly systematic, multi-pronged in its approach, and includes both primary as well as secondary research to determine leading products, players, market size, applications, distributors, industry connotations, and others. The data extracted from primary and secondary research undergoes several layers of validation and cross-verification. The team of experts have many years of experience in diverse domains and their recommendations can be very useful indeed. The primary and secondary data is combined with analyst opinions’ via a triangulation method to deliver an unbiased report on the hyaluronic acid products market. To ensure fool-proof accuracy, information is only gathered from authoritative sources such as industry publications, government websites, trade journals, company statements, and press releases. Lastly, the data is thoroughly scrutinized with the help of advanced company tools to glean all the qualitative and quantitative insights of the hyaluronic acid products market.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Hyaluronic Acid Products Market Overview
3. Hyaluronic Acid Products Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Reimbursement Guide for Hyaluronic Acid Products
3.4. Key Regulations
4. North America Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
4.5.1. Single Cycle Injection Products
4.5.2. Three Cycle Injection Products
4.5.3. Five Cycle Injection Products
4.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
4.6.1. Single Cycle Injection Products
4.6.2. Three Cycle Injection Products
4.6.3. Five Cycle Injection Products
4.7. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
4.7.1. Osteoarthritis
4.7.2. Ophthalmic
4.7.3. Dermal Fillers
4.7.4. Vesicoureteral Reflux
4.8. Market Size (US$ Mn) Forecast By Application, 2017-2027
4.8.1. Osteoarthritis
4.8.2. Ophthalmic
4.8.3. Dermal Fillers
4.8.4. Vesicoureteral Reflux
4.9. Drivers and Restraints: Impact Analysis
4.10.Market Attractiveness Analysis
4.10.1. By Country
4.10.2. By Product Type
4.10.3. By Application
4.11. Key Representative Market Participants
4.12. Key Participants Market Presence (Intensity Map)
5. Latin America Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Regional Market Dynamics
5.5.1. Drivers
5.5.2. Restraints
5.5.3. Trends
5.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
5.6.1. Single Cycle Injection Products
5.6.2. Three Cycle Injection Products
5.6.3. Five Cycle Injection Products
5.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
5.7.1. Single Cycle Injection Products
5.7.2. Three Cycle Injection Products
5.7.3. Five Cycle Injection Products
5.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
5.8.1. Osteoarthritis
5.8.2. Ophthalmic
5.8.3. Dermal Fillers
5.8.4. Vesicoureteral Reflux
5.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
5.9.1. Osteoarthritis
5.9.2. Ophthalmic
5.9.3. Dermal Fillers
5.9.4. Vesicoureteral Reflux
5.10. Drivers and Restraints: Impact Analysis
5.11. Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Product Type
5.11.3. By Application
5.12. Key Representative Market Participants Key Participants Market Presence (Intensity Map)
6. Western Europe Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) and Volume Analysis By Country, 2012-2016
6.3.1. Germany
6.3.2. United Kingdom
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Nordics
6.3.7. Rest of Western Europe
6.4. Market Size (US$ Mn) and Volume Forecast By Country, 2017-2027
6.4.1. Germany
6.4.2. United Kingdom
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Nordics
6.4.7. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
6.5.1. Single Cycle Injection Products
6.5.2. Three Cycle Injection Products
6.5.3. Five Cycle Injection Products
6.6. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
6.6.1. Single Cycle Injection Products
6.6.2. Three Cycle Injection Products
6.6.3. Five Cycle Injection Products
6.7. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
6.7.1. Osteoarthritis
6.7.2. Ophthalmic
6.7.3. Dermal Fillers
6.7.4. Vesicoureteral Reflux
6.8. Market Size (US$ Mn) Forecast By Application, 2017-2027
6.8.1. Osteoarthritis
6.8.2. Ophthalmic
6.8.3. Dermal Fillers
6.8.4. Vesicoureteral Reflux
6.9. Drivers and Restraints: Impact Analysis
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Product Type
6.10.3. By Application
6.11. Key Representative Market Participants
6.12. Key Participants Market Presence (Intensity Map)
7. Eastern Europe Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Regional Market Dynamics
7.5.1. Drivers
7.5.2. Restraints
7.5.3. Trends
7.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
7.6.1. Single Cycle Injection Products
7.6.2. Three Cycle Injection Products
7.6.3. Five Cycle Injection Products
7.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
7.7.1. Single Cycle Injection Products
7.7.2. Three Cycle Injection Products
7.7.3. Five Cycle Injection Products
7.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
7.8.1. Osteoarthritis
7.8.2. Ophthalmic
7.8.3. Dermal Fillers
7.8.4. Vesicoureteral Reflux
7.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
7.9.1. Osteoarthritis
7.9.2. Ophthalmic
7.9.3. Dermal Fillers
7.9.4. Vesicoureteral Reflux
7.10. Drivers and Restraints: Impact Analysis
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Product Type
7.11.3. By Application
7.12. Key Representative Market Participants
7.13. Key Participants Market Presence (Intensity Map)
8. Japan Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Regional Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Trends
8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
8.4.1. Single Cycle Injection Products
8.4.2. Three Cycle Injection Products
8.4.3. Five Cycle Injection Products
8.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
8.5.1. Single Cycle Injection Products
8.5.2. Three Cycle Injection Products
8.5.3. Five Cycle Injection Products
8.6. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
8.6.1. Osteoarthritis
8.6.2. Ophthalmic
8.6.3. Dermal Fillers
8.6.4. Vesicoureteral Reflux
8.7. Market Size (US$ Mn) Forecast By Application, 2017-2027
8.7.1. Osteoarthritis
8.7.2. Ophthalmic
8.7.3. Dermal Fillers
8.7.4. Vesicoureteral Reflux
8.8. Drivers and Restraints: Impact Analysis
8.9. Market Attractiveness Analysis
8.9.1. By Product Type
8.9.2. By Application
8.10. Key Representative Market Participants
8.11. Key Participants Market Presence (Intensity Map)
9. Asia Pacific Excluding Japan Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
9.3.1. China
9.3.2. India
9.3.3. Australia and New Zealand
9.3.4. ASEAN
9.3.5. Rest of APEJ
9.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
9.4.1. China
9.4.2. India
9.4.3. Australia and New Zealand
9.4.4. ASEAN
9.4.5. Rest of APEJ
9.5. Regional Market Dynamics
9.5.1. Drivers
9.5.2. Restraints
9.5.3. Trends
9.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
9.6.1. Single Cycle Injection Products
9.6.2. Three Cycle Injection Products
9.6.3. Five Cycle Injection Products
9.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
9.7.1. Single Cycle Injection Products
9.7.2. Three Cycle Injection Products
9.7.3. Five Cycle Injection Products
9.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
9.8.1. Osteoarthritis
9.8.2. Ophthalmic
9.8.3. Dermal Fillers
9.8.4. Vesicoureteral Reflux
9.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
9.9.1. Osteoarthritis
9.9.2. Ophthalmic
9.9.3. Dermal Fillers
9.9.4. Vesicoureteral Reflux
9.10. Drivers and Restraints: Impact Analysis
9.11. Market Attractiveness Analysis
9.11.1. By Country
9.11.2. By Product Type
9.11.3. By Application
9.12. Key Representative Market Participants
9.13. Key Participants Market Presence (Intensity Map)
10. Middle East and Africa Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of Middle East and Africa
10.4. Market Size (US$ Mn) Forecast By Country, 2017-2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East and Africa
10.5. Regional Market Dynamics
10.5.1. Drivers
10.5.2. Restraints
10.5.3. Trends
10.6. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
10.6.1. Single Cycle Injection Products
10.6.2. Three Cycle Injection Products
10.6.3. Five Cycle Injection Products
10.7. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
10.7.1. Single Cycle Injection Products
10.7.2. Three Cycle Injection Products
10.7.3. Five Cycle Injection Products
10.8. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
10.8.1. Osteoarthritis
10.8.2. Ophthalmic
10.8.3. Dermal Fillers
10.8.4. Vesicoureteral Reflux
10.9. Market Size (US$ Mn) Forecast By Application, 2017-2027
10.9.1. Osteoarthritis
10.9.2. Ophthalmic
10.9.3. Dermal Fillers
10.9.4. Vesicoureteral Reflux
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Product Type
10.11.3. By Application
10.12. Key Representative Market Participants
10.13. Key Participants Market Presence (Intensity Map)
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Competition Dashboard
13.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.2.1. Allergan plc
13.2.2. Anika Therapeutics Inc.
13.2.3. Shanghai Jingfeng Pharmaceutical Co., Ltd.
13.2.4. Ferring Pharmaceuticals
13.2.5. Galderma SA (Nestle Skin Health Company)
13.2.6. Sanofi
13.2.7. Salix Pharmaceuticals Ltd. (Sub. Valeant)
13.2.8. Smith & Nephew
13.2.9. Zimmer Biomet
13.2.10. Seikagaku Corporation
13.2.11. Fidia Farmaceutici s.p.a.
14. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027 By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Japan
14.2.6. Asia Pacific Excluding Japan
14.2.7. Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Region, 2017-2027
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Japan
14.3.6. Asia Pacific Excluding Japan
14.3.7. Middle East and Africa
14.4. Market Attractiveness Analysis By Region
15. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type
15.1. Introduction/Key Finding
15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
15.2.1. Single Cycle Injection Products
15.2.2. Three Cycle Injection Products
15.2.3. Five Cycle Injection Products
15.3. Market Size (US$ Mn) Forecast By Product Type, 2017-2027
15.3.1. Single Cycle Injection Products
15.3.2. Three Cycle Injection Products
15.3.3. Five Cycle Injection Products
15.4. Market Attractiveness Analysis By Product Type
16. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027, By Application
16.1. Introduction/Key Finding
16.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2016
16.2.1. Osteoarthritis
16.2.2. Ophthalmic
16.2.3. Dermal Fillers
16.2.4. Vesicoureteral Reflux
16.3. Market Size (US$ Mn) Forecast By Application, 2017-2027
16.3.1. Osteoarthritis
16.3.2. Ophthalmic
16.3.3. Dermal Fillers
16.3.4. Vesicoureteral Reflux
16.4. Market Attractiveness Analysis By Application
17. Global Hyaluronic Acid Products Market Analysis 2012–2016 and Forecast 2017–2027
17.1. Market Size and Y-o-Y Growth
17.2. Absolute $ Opportunity
17.3. Value Chain
18. Assumptions and Acronyms Used
19. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report